StonvexLoading…
StonvexStonvexStonvexCore line items from ENR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.42B | $778.90M | $2.95B | $2.12B |
Operating Income | $16.90M | $-4.80M | $284.10M | $230.70M |
Net Income | $6.70M | $-3.40M | $239.00M | $204.10M |
EPS (Diluted) | $0.10 | $-0.05 | $3.32 | $2.84 |
Total Assets | $4.40B | $4.44B | $4.56B | $4.52B |
Total Liabilities | $4.23B | $4.30B | $4.39B | $4.33B |
Cash & Equivalents | $172.50M | $214.80M | $236.20M | $171.10M |
Free Cash Flow OCF − CapEx | $104.80M | $124.20M | $63.20M | $16.50M |
Shares Outstanding | 69.20M | 68.40M | 72.00M | 72.90M |